We are focused in the development of advanced drug delivery therapies based on polymeric micro and/or nanoparticles, and the development of novel biomaterials for nanotherapeutics.
As an applied science that opens a world of creative possibilities, impacting almost all areas of society and contributing to significant global economic growth, nanotechnology has been compared to the industrial revolution of the 21st century. The term nanotechnology refers to the manufacturing and utilization of materials, devices, and systems in the 0.1-100 nm dimension range. The US National Nanotechnology Initiative has defined the concept of nanotechnology as "the understanding and control of matter that involves imaging, measuring, modeling, and manipulating matter at the nanoscale, where unique phenomena enable novel applications".
Nanotechnology involves the design and development of novel nanostructures that have improved the efficiency of industrial processes and promoted the development in fields such as energy, the environment, materials, and medicine.
Given the broad platform of applications that nanotechnology offers in life sciences, and the inherent nanoscale functions of the biological mechanisms that form living cells, nanobiotechnology has been an emerging research domain in nanotechnology. Nanobiotechnology has been pivotal to many significant advances in the methods currently used for diagnostics, biomedical imaging, biosensors, and drug delivery systems.
Nanomedicine includes the development of nanodevices and nanoanalytical techniques for the molecular diagnostics, treatment, and prevention of disease (in terms of pain reduction and preserving or improving human health).
Drug delivery is a key component in the development of nanomedicine. Drug delivery based on nanoparticles include the intracellular delivery of macromolecules, improvements in poorly water-soluble drugs, the co-liberation of therapeutic agents, and the improvement of effective therapies that transcend the epithelial and endothelial barriers. In addition, advanced therapeutic strategies based on nanoparticles are allowed to targeted delivery of drugs to specific cell-tissues. In several cases, the nanoarchitecture of nanocarriers is a perfect example of engineering that combines cellular components and nanomaterials technology. Currently, there is a broad range of nanocarriers—such as liposomes, dendrimers, polymeric micelles, polymeric nanoparticles —that continually promise to revolutionize the future of medicine.